Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Deconstructing antiseizure mechanisms of anterior thalamic nucleus electrical stimulation

$5.47M USD

Funder NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
Recipient Organization Emory University
Country United States
Start Date Aug 20, 2024
End Date Jun 30, 2029
Duration 1,775 days
Number of Grantees 2
Roles Co-Investigator; Principal Investigator
Data Source NIH (US)
Grant ID 10812858
Grant Description

PROJECT SUMMARY/ABSTRACT Epilepsy is one of the most prevalent neurological disorders. Patients with epilepsy experience abnormal brain activity causing seizures or periods of unusual behavior, sensations, and often loss of awareness or consciousness. Deep brain stimulation of the anterior nucleus of the thalamus (ANT-DBS) is an approved

therapy that effectively reduces seizures in many patients with drug resistant epilepsy, but very rarely leads to all-important complete freedom from disabling seizures. This gap in treatment effectiveness may stem from limited understanding of the mechanism underlying ANT-DBS, as it remains unknown not only which areas of a

complex neuronal network ANT-DBS must modulate, but also how those structures are modulated, to achieve its therapeutic effect. We hypothesize that ANT-DBS results in direct, local inhibition of ANT neurons, and its downstream pathway. We propose a set of experiments to identify and modulate the neuronal network

components that mediate ANT-DBS effectiveness, using the intrahippocampal kainic acid mouse model of temporal lobe epilepsy. We will first determine whether ANT neurons contribute to the seizure suppressive effect of ANT-DBS by ablating or modulating subpopulations of intrinsic neurons (Aim1). We then will examine whether

the ANT-retrosplenial cortex (RSCx) pathway is a necessary conduit for ANT- DBS to be effective, by manipulating RSCx neurons that receive direct input from the ANT (Aim 2). Finally, we will test the hypothesis that ANT-DBS might suppress seizure by inhibiting afferent axons from areas projecting to the ANT, such as the

mammillary bodies (Aim 3). Identifying the circuit mechanism of ANT-DBS would improve patient outcomes by leading to more precise guidelines for improved device targeting, prediction of patients that respond to ANT- DBS, and pave the way for novel therapies that can target this seizure-resistant network or use similar

mechanisms.

All Grantees

Emory University

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant